We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRO icon
4751
Spero Therapeutics
SPRO
$71.2M
$1.75K ﹤0.01%
+603
New +$867
WFCF icon
4752
Where Food Comes From
WFCF
$62.5M
$1.75K ﹤0.01%
+158
New +$1.69K
XLY icon
4753
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$1.74K ﹤0.01%
16
-187,614
-100% -$19.2M
DRD
4754
DRDGold
DRD
$2.05B
$1.73K ﹤0.01%
130
+122
+1,525% +$1.8K
GNSS icon
4755
Genasys
GNSS
$74.7M
$1.73K ﹤0.01%
997
-3,044
-75% -$5.62K
RAIL icon
4756
FreightCar America
RAIL
$259M
$1.72K ﹤0.01%
200
-3,327
-94% -$23.2K
LIDR icon
4757
AEye
LIDR
$60.2M
$1.71K ﹤0.01%
1,662
-16
-1% -$11
LEXX icon
4758
Lexaria Bioscience
LEXX
$9.07M
$1.71K ﹤0.01%
131
+44
+51% +$758
TSBX
4759
DELISTED
Turnstone Biologics
TSBX
$1.7K ﹤0.01%
4,741
-20
-0.4% -$7
GANX icon
4760
Gain Therapeutics
GANX
$75.5M
$1.7K ﹤0.01%
945
-1,487
-61% -$2.75K
KMTS
4761
Kestra Medical Technologies
KMTS
$1.66B
$1.69K ﹤0.01%
+102
New +$2.23K
SIL icon
4762
Global X Silver Miners ETF NEW
SIL
$4.83B
$1.69K ﹤0.01%
+35
New +$1.49K
JRSH icon
4763
Jerash Holdings
JRSH
$65.7M
$1.68K ﹤0.01%
513
-28
-5% -$88
FBIO icon
4764
Fortress Biotech
FBIO
$91.4M
$1.68K ﹤0.01%
+904
New +$1.57K
BNED icon
4765
Barnes & Noble Education
BNED
$444M
$1.66K ﹤0.01%
141
-4,886
-97% -$52.1K
CWD icon
4766
CaliberCos
CWD
$4.47M
$1.66K ﹤0.01%
470
+298
+173% +$1.57K
EPR.PRC icon
4767
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$145M
$1.65K ﹤0.01%
66
+29
+78% +$674
OLB icon
4768
OLB
OLB
$4.54M
$1.65K ﹤0.01%
883
-2,972
-77% -$4.61K
CVKD icon
4769
Cadrenal Therapeutics
CVKD
$6.92M
$1.64K ﹤0.01%
+136
New +$2.02K
VIG icon
4770
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.64K ﹤0.01%
8
-1
-11% -$194
ELAB icon
4771
Elevai Labs
ELAB
$4.18M
$1.62K ﹤0.01%
9
-5
-36% -$1.08K
POCI icon
4772
Precision Optics
POCI
$46.4M
$1.62K ﹤0.01%
331
+35
+12% +$154
AMDG
4773
Leverage Shares 2X Long AMD Daily ETF
AMDG
$27.3M
$1.62K ﹤0.01%
+100
New +$1.01K
UVXY icon
4774
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
$1.61K ﹤0.01%
17
-4,589
-100% -$608K
GTBP icon
4775
GT Biopharma
GTBP
$11.6M
$1.61K ﹤0.01%
450
-468
-51% -$1.21K

Similar funds

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.